Interaction of Matrix Metalloproteinases with Serine Protease Inhibitors
1994; Wiley; Volume: 732; Issue: 1 Linguagem: Inglês
10.1111/j.1749-6632.1994.tb24745.x
ISSN1749-6632
AutoresSatish Mallya, J. Edward Hall, H M Lee, Elizabeth J. Roemer, Sanford R. Simon, LORNE M. GOLUB,
Tópico(s)Protease and Inhibitor Mechanisms
ResumoAnnals of the New York Academy of SciencesVolume 732, Issue 1 p. 303-314 Interaction of Matrix Metalloproteinases with Serine Protease Inhibitors New Potential Roles for Matrix Metalloproteinase Inhibitorsa SATISH K. MALLYA, SATISH K. MALLYA Department of Biochemistry and Cell Biology, State University of New York at Stony Brook Stony Brook, New York 11794Search for more papers by this authorJOSEPH E. HALL, JOSEPH E. HALL Department of Pediatrics, State University of New York at Stony Brook Stony Brook, New York 11794Search for more papers by this authorHSI-MING LEE, HSI-MING LEE Department of Oral Biology and Pathology, State University of New York at Stony Brook Stony Brook, New York 11794Search for more papers by this authorELIZABETH J. ROEMER, ELIZABETH J. ROEMER Department of Pathology, State University of New York at Stony Brook Stony Brook, New York 11794Search for more papers by this authorSANFORD R. SIMON, Corresponding Author SANFORD R. SIMON Department of Biochemistry and Cell Biology, State University of New York at Stony Brook Stony Brook, New York 11794 Department of Pathology, State University of New York at Stony Brook Stony Brook, New York 11794Address correspondence to Sanford R. Simon, Ph.D., Department of Pathology, State University of New York at Stony Brook, Stony Brook, New York 11794-8691.Search for more papers by this authorLORNE M. GOLUB, LORNE M. GOLUB Department of Oral Biology and Pathology, State University of New York at Stony Brook Stony Brook, New York 11794Search for more papers by this author SATISH K. MALLYA, SATISH K. MALLYA Department of Biochemistry and Cell Biology, State University of New York at Stony Brook Stony Brook, New York 11794Search for more papers by this authorJOSEPH E. HALL, JOSEPH E. HALL Department of Pediatrics, State University of New York at Stony Brook Stony Brook, New York 11794Search for more papers by this authorHSI-MING LEE, HSI-MING LEE Department of Oral Biology and Pathology, State University of New York at Stony Brook Stony Brook, New York 11794Search for more papers by this authorELIZABETH J. ROEMER, ELIZABETH J. ROEMER Department of Pathology, State University of New York at Stony Brook Stony Brook, New York 11794Search for more papers by this authorSANFORD R. SIMON, Corresponding Author SANFORD R. SIMON Department of Biochemistry and Cell Biology, State University of New York at Stony Brook Stony Brook, New York 11794 Department of Pathology, State University of New York at Stony Brook Stony Brook, New York 11794Address correspondence to Sanford R. Simon, Ph.D., Department of Pathology, State University of New York at Stony Brook, Stony Brook, New York 11794-8691.Search for more papers by this authorLORNE M. GOLUB, LORNE M. GOLUB Department of Oral Biology and Pathology, State University of New York at Stony Brook Stony Brook, New York 11794Search for more papers by this author First published: September 1994 https://doi.org/10.1111/j.1749-6632.1994.tb24745.xCitations: 14 a This work was supported by grants from the Smokeless Tobacco Research Council, SUSB Biotechnology Center (NYS Office of Science and Technology), Collaborative Laboratories, Cortech Inc., and National Institutes of Health (NHLBI R01-HL-14262 to S.R.S. and NIDR R37-DE-03987 to L.M.G.). AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Rinehart, A. R., S. K. Mallya & S. R. Simon 1993. Human α1-proteinase inhibitor binds to extracellular matrix in vitro with retention of inhibitory activity. Am. J. Respir. Cell Mol. Biol. 9: 666–679. 2 Travis, J., A. Dubin, J. Potema, W. Watorek & A. Kurdowska 1991. Neutrophil proteinases. Caution signs in designing inhibitors against enzymes with possible multiple functions. Ann. N. Y. Acad. Sci. 624: 81–86. 3 Knauper, V., H. Reinke & H. Tschesche 1990. Inactivation of human α1-proteinase inhibitor by human PMN collagenase. FEBS Lett. 263: 355–357. 4 Michaelis, J., M. C. M. Vissers & C. C. Winterbourn 1990. Human neutrophil collagenase cleaves α-1antitrypsin. Biochem. J. 270: 809–814. 5 Winyard, P. G., Z. Chang, K. Chidwick, D. R. Blake, R. W. Carrell & G. Murphy 1991. Proteolytic inactivation of human α1-antitrypsin by human stromelysin. FEBS Lett. 279: 91–94. 6 Golub, L. M., R. A. Greenwald, N. S. Ramamurthy, T. F. McNamara & B. R. Rifkin 1991. Tetracyclines inhibit connective tissue breakdown: New therapeutic implications for an old family of drugs. Crit. Rev. Oral. Biol. Med. 2: 297–322. 7 Sorsa, T., O. Lindy, Y. T. Konttinen, K. Suomalainen, T. Ingman, H. Saari, S. Halinen, H.-M. Lee, L. M. Golub, J. E. Hall & S. R. Simon 1993. Doxycycline in the protection of serum alpha-1-antitrypsin from human neutrophil collagenase and gelatinase. Antimicrob. Agents Chemother. 37: 592–594. 8 Roemer, E. J., K. J. Stanton & S. R. Simon 1994. In vitro assay systems for inflammatory cell-mediated damage to interstitial extracellular matrix. In Vitro Toxicol. 7: 75–81. 9 Rinehart, A. R. & S. R. Simon 1991. Human α1-roteinase inhibitor binds to extracellular matrix in vitro with retention of inhibitory activity. J. Cell. Biochem. Suppl. 15G: 152. 10 Jones, P. A., T. Scott-Burden & W. Gevers 1979. Glycoprotein, elastin, and collagen secretion by rat smooth muscle cells. Proc. Natl. Acad. Sci. USA. 76: 353–357. 11 Kalmar, J. R., R. R. Arnold, M. L. Warbington & M. K. Gardner 1988. Superior leukocyte separation with a discontinuous one-step Ficoll-Hypaque gradient for the isolation of human neutrophils. J. Immunol. Methods. 110: 275–281. 12 Mookhtiar, K. A. & H. E. Van Wart 1990. Purification of human neutrophil collagenase to homogeneity. Biochemistry. 29: 10623–10627. 13 Desrochers, P. E., K. Mookhtiar, H. E. Van Wart, K. A. Hasty & S. J. Weiss 1992. Proteolytic inactivation of α1-proteinase inhibitor and α1-antichymotrypsin by oxidatively inactivated human neutrophil metalloproteinases. J. Biol. Chem. 267: 5005–5012. 14 Cerra, F. B. 1992. Multiple organ failure syndrome. Disease-a-Month. 38: 847–895. 15 Lee, C. T., A. M. Fain & M. Lippman 1981. Elastolytic activity in pulmonary lavage from patients with adult respiratory distress syndrome. N. Engl. J. Med. 304: 192–196. 16 Horl, W. H. & A. Heidland 1983. Proteases II: Potential role in health and disease. Adv. Exp. Med. Biol. 240. 17 Howard, E. W. & M. J. Banda 1991. Binding of tissue inhibitor of metalloproteinases 2 to two distinct sites on human 72 kDa gelatinase. J. Biol. Chem. 266: 17972–17977. 18 Janoff, A. 1985. Elastases and emphysema: Current assessment of the proteaseantiprotease hypothesis. Am. Rev. Respir. Dis. 132: 417–423. 19 Crystal, R. G. 1990. Alpha-1-antitrypsin deficiency, emphysema and liver disease: Genetic bases and strategies for therapy. J. Clin. Invest. 85: 1434–1452. 20 Pryor, W. A., M. Dooley & D. F. Church 1984. Inactivation of human plasma α1-proteinase inhibitor by gas phase cigarette smoke. Biochem. Biophys. Res. Commun. 122: 676–681. 21 Weiss, S. J. 1989. Tissue destruction by neutrophils. N. Engl. J. Med. 320: 365–376. 22 Bucurenci, N., B. R. Blake, K. Chidwick & P. G. Winyard 1992. Inhibition of neutrophil superoxide production by human plasma α1-antitrypsin. FEBS Lett. 300: 21–24. 23 Mast, A. E., J. J. Enghild, H. Nagase, K. Suzuki, S. V. Pizzo & G. Salvesen 1991. Kinetics and physiologic relevance of the inactivation of α1-proteinase inhibitor, α1-antichymotrypsin and antithrombin III by matrix metalloproteinase-1 (tissue collagenase) and -2 (72 kDa gelatinasesol;type IV collagenase) and -3 (stromelysin). J. Biol. Chem. 266: 15810–15816. 24 Hasty, K. A., J. J. Jeffrey, M. S. Hibbs & H. G. Welgus 1987. Collagen substrate specificity of human neutrophil collagenase. J. Biol. Chem. 262: 10048–10052. 25 Mecham, R. P. & J. Heuser 1990. Three-dimensional organization of extracellular matrix in elastic cartilage as viewed by quick freeze deep etch electron microscopy. Connect. Tissue Res. 24: 83–93. 26 Golub, L. M., T. F. McNamara, G. D. D'Angelo, R. A. Greenwald & N. S. Ramamurthy 1987. A non-antibacterial chemically modified tetracycline inhibits mammalian collagenase activity. J. Dent. Res. 66: 1310–1314. 27 Suomalainen, K., T. Sorsa, L. M. Golub, N. S. Ramamurthy, H.-M. Lee, V.-J. Uitto, H. Saari & Y. T. Konttinen 1992. Specificity of the anticollagenase actions of the tetracyclines: Relevance to their anti-inflammatory potential. Antimicrob. Agents Chemother. 36: 227–229. 28 Banda, M. J., A. G. Rice, G. L. Griffin & R. M. Senior 1988. α1-proteinase inhibitor is a neutrophil chemoattractant after proteolytic inactivation by macrophage elastase. J. Biol. Chem. 263: 4481–4484. 29 Weiss, S. J. & S. Regiani 1984. Neutrophils degrade subendothelial matrices in the presence of α1-proteinase inhibitor. J. Clin. Invest. 73: 1297–1303. 30 Furie, M. B., B. L. Naprstek & S. C. Silverstein 1987. Migration of neutrophils across monolayers of cultured microvascular endothelial cells. J. Cell Sci. 88: 161–175. 31 Salonen, E. M., A. Vaheri, J. Pollanen, R. Stephens, P. Andreasen, M. F. Mayer, K. Dano, J. Gallit & E. Ruoslahti 1989. Interaction of plasminogen activator inhibitor-1 (PAI-1) with vitronectin. J. Biol. Chem. 264: 6339–6343. 32 Chapman, H. A., X. Yang, L. Z. Sailor & D. J. Sugarbaker 1990. Developmental expression of plasminogen activator inhibitor type 1 by human alveolar macrophage: Possible role in lung injury. J. Immunol. 145: 3398–3405. 33 Morrison, H. M., H. G. Welgus, R. A. Stockley, D. Burnett & E. J. Campbell 1990. Inhibition of human leukocyte elastase bound to elastin: Relative ineffectiveness and two mechanisms of inhibitory activity. Am. J. Respir. Cell Mol. Biol. 2: 263–269. 34 Padrines, M. & J. G. Bieth 1991. Elastin decreases the efficiency of neutrophil elastase inhibitors. Am. J. Respir. Cell Mol. Biol. 4: 187–193. 35 Lee, H. M., J. E. Hall, T. Sorsa, S. R. Simon & L. M. Golub 1992. Doxycycline inhibits PMN-mediated tissue breakdown in culture. J. Dent. Res. 71: 245. 36 Yu, L. P., G. N. Smith, K. A. Hasty & K. D. Brandt 1991. Doxycycline inhibits type XI collagenolytic activity of extracts of human osteoarthritic cartilage and of gelantinase. J. Rheumatol. 18: 1450–1452. Citing Literature Volume732, Issue1Inhibition of Matrix Metalloproteinases: Therapeutic PotentialSeptember 1994Pages 303-314 ReferencesRelatedInformation
Referência(s)